Barry J. Moze
2021
Compensation breakdown
| Non-Equity Incentive Plan | $1,015,605 |
|---|---|
| Option Awards | $226,095 |
| Salary | $650,913 |
| Stock Awards | $8,431,748 |
| Other | $145,044 |
| Total | $10,469,404 |
Moze received $8.4M in stock awards, accounting for 81% of the total pay in 2021.
Moze also received $1M in non-equity incentive plan, $226.1K in option awards, $650.9K in salary and $145K in other compensation.
Rankings
In 2021, Barry J. Moze's compensation ranked 967th out of 12,397 executives tracked by ExecPay. In other words, Moze earned more than 92.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 967 out of 12,397 | 92nd |
Division Manufacturing | 323 out of 5,492 | 94th |
Major group Chemicals And Allied Products | 108 out of 2,367 | 95th |
Industry group Drugs | 91 out of 2,090 | 96th |
Industry Pharmaceutical Preparations | 60 out of 1,537 | 96th |
Pay ratio
| Barry J. Moze's Pay | $10,469,404 |
|---|---|
| Median Employee's Pay | $298,200 |
| Pay Ratio | 35to 1 |
In 2021, the annual total compensation of Barry J. Moze was $10,469,404.
The annual total compensation of the median employee at Horizon Pharma was $298,200.
The ratio of Barry J. Moze's pay to the pay of median employee was therefore 35 to one.
Moze's colleagues
We found five more compensation records of executives who worked with Barry J. Moze at Horizon Pharma in 2021.
2021
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2021
Brian Beeler
Horizon Pharma
General Counsel
2021
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
2021
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
2021
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019